FDA Flags Missing Trial Results - Summary - MDSpire
FDA & Government News

FDA Flags Missing Trial Results

Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available

Share

The FDA has reminded over 2,200 medical companies and researchers about their obligation to submit clinical trial results to ClinicalTrials.gov, highlighting significant reporting gaps. Analysis shows 29.6% of studies that should have reported results did not, potentially leading to publication bias that skews the perception of product safety. The FDA emphasized the importance of transparency in reporting, stating that withholding unfavorable data undermines informed decision-making for doctors and patients. The agency is taking steps to enhance compliance ahead of potential regulatory actions.

Original Source(s)

FDA Flags Missing Trial Results

  • by Kathryn Wighton

  • April 13, 2026

Related Content

Can Nasal Nitric Oxide Aid PCD Diagnosis?

Evidence synthesis shows strong diagnostic performance but highlights variability across subgroups and clinical settings

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Utah Just Let an Algorithm Write Prescriptions

Physician oversight waived in state sandbox; federal review status unclear